Pharming Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	369.45	376.13	297.2	245.32	205.62	198.87
Revenue Growth (YoY)	15.20%	26.56%	21.15%	19.30%	3.40%	-6.27%
Cost of Revenue	43.84	45.5	35.4	25.21	17.56	21.14
Gross Profit	325.6	330.63	261.8	220.1	188.06	177.73
Selling, General & Admin	199.43	210.95	189.45	179.93	131.82	96.42
Research & Development	104.76	100.37	83.15	68.91	52.53	70.37
Other Operating Expenses	297.71	304.79	270.42	225.49	169.83	164.17
Total Operating Expenses	601.91	616.11	543.02	474.33	354.18	330.96
Operating Income	27.89	25.84	-8.62	-5.39	18.23	13.56
Interest Income	6.95	2.8	5.08	3.37	3.4	15.59
Interest Expense	-7.4	-18.14	-9.94	-9.07	-5.46	-6.19
Other Non-Operating Income (Expense)	-	2.35	4.99	-0.93	-1.19	0.11
Total Non-Operating Income (Expense)	-0.44	-13	0.13	-6.63	-3.25	9.52
Pretax Income	19.85	12.85	-8.49	-12.01	14.99	23.08
Provision for Income Taxes	-5.16	-10.31	-3.35	1.46	-1.31	-7.08
Net Income	12.19	2.54	-11.84	-10.55	13.67	16
Minority Interest in Earnings	-	-0.31	-	-	-	-
Net Income to Common	12.19	2.85	-11.84	-10.55	13.67	16
Net Income Growth	-	-	-	-	-14.52%	-57.62%
Shares Outstanding (Basic)	64	69	67	66	65	64
Shares Outstanding (Diluted)	76	75	79	73	71	70
Shares Change (YoY)	-1.73%	-4.91%	8.26%	2.59%	0.85%	2.70%
EPS (Basic)	0.19	0.04	-0.18	-0.16	0.21	0.25
EPS (Diluted)	0.16	0.04	-0.18	-0.16	0.19	0.23
EPS Growth	-	-	-	-	-17.39%	-58.18%
Free Cash Flow	55.72	53.96	-2.59	-18.74	21.08	27.1
Free Cash Flow Growth	3.27%	-	-	-	-22.21%	-65.68%
Free Cash Flow Per Share	0.73	0.72	-0.03	-0.26	0.30	0.39
Gross Margin	88.13%	87.90%	88.09%	89.72%	91.46%	89.37%
Operating Margin	7.55%	6.87%	-2.90%	-2.20%	8.87%	6.82%
Profit Margin	3.30%	0.67%	-3.98%	-4.30%	6.65%	8.04%
FCF Margin	15.08%	14.35%	-0.87%	-7.64%	10.25%	13.63%
EBITDA	39.64	37.06	7.45	10.54	31.42	33.17
EBITDA Margin	10.73%	9.85%	2.51%	4.30%	15.28%	16.68%
EBIT	27.89	25.84	-8.62	-5.39	18.23	13.56
EBIT Margin	7.55%	6.87%	-2.90%	-2.20%	8.87%	6.82%
Effective Tax Rate	-25.99%	-80.25%	39.44%	-12.19%	-8.76%	-30.69%

SEC Filings: 10-K · 10-Q